This inventor holds 13 USPTO granted patents. Top assignee: The Dow Chemical Company. Active years: 1976-1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976-1980
Title: The Innovative Contributions of Donald L. Trepanier
Introduction
Donald L. Trepanier is a notable inventor based in Midland, MI (US), recognized for his significant contributions to the field of chemistry. With a total of 13 patents to his name, Trepanier has made remarkable advancements in the development of psychoactive compounds and methods for treating central nervous system disorders.
Latest Patents
Among his latest patents, Trepanier has developed a method for preparing 6-phenyl-triazolo compounds. This innovative process involves the synthesis of novel triazolo- or imidazo-benzotriazepines derived from 1,3,4-benzotriazepine-2-thiones, which are in turn prepared from a 2-aminobenzophenone. Additionally, he has worked on psychoactive 1,3,4-benzotriazepine-2-thiones and methods for treating symptoms associated with central nervous system depression and anxiety.
Career Highlights
Trepanier's career is marked by his association with The Dow Chemical Company, where he has been able to apply his expertise in chemistry to develop innovative solutions. His work has not only contributed to the company's portfolio but has also advanced the scientific community's understanding of psychoactive compounds.
Collaborations
Throughout his career, Trepanier has collaborated with various professionals, including his coworker Thomas C. Britton. These collaborations have fostered an environment of innovation and have led to the successful development of several patents.
Conclusion
Donald L. Trepanier's contributions to the field of chemistry and his innovative patents have made a significant impact on the development of psychoactive compounds. His work continues to influence the industry and improve treatment options for central nervous system disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
